14
Participants
Start Date
March 15, 2017
Primary Completion Date
August 3, 2023
Study Completion Date
November 1, 2023
Ceramide NanoLiposome
Intravenous administration of Ceramide NanoLiposome
University of Maryland, Greenebaum Cancer Center, Baltimore
University of Virginia Cancer Center, Charlottesville
Medical University of South Carolina, Hollings Cancer Center, Charleston
Lead Sponsor
National Institutes of Health (NIH)
NIH
National Cancer Institute (NCI)
NIH
Keystone Nano, Inc
INDUSTRY